Literature DB >> 17135458

Self-reported health in people with Parkinson's disease left untreated at diagnosis.

Peter Hagell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17135458      PMCID： PMC2117842          DOI： 10.1136/jnnp.2006.109454

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  6 in total

Review 1.  Rating scales for neurologists.

Authors:  J Hobart
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

Review 2.  Outcome measures for clinical trials in Parkinson's disease: achievements and shortcomings.

Authors:  Connie Marras; Antony E Lang
Journal:  Expert Rev Neurother       Date:  2004-11       Impact factor: 4.618

Review 3.  Timing of treatment initiation in Parkinson's disease: a need for reappraisal?

Authors:  Anthony H V Schapira; Jose Obeso
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

4.  Treatment should not be initiated too soon in Parkinson's disease.

Authors:  Michael J Aminoff
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

5.  Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations.

Authors:  H Reichmann; J Boas; D Macmahon; V Myllyla; A Hakala; K Reinikainen
Journal:  Acta Neurol Scand       Date:  2005-01       Impact factor: 3.209

6.  A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis.

Authors:  D Grosset; L Taurah; D J Burn; D MacMahon; A Forbes; K Turner; A Bowron; R Walker; L Findley; O Foster; K Patel; C Clough; B Castleton; S Smith; G Carey; T Murphy; J Hill; U Brechany; P McGee; S Reading; G Brand; L Kelly; K Breen; S Ford; M Baker; A Williams; J Hearne; N Qizilbash; K Ray Chaudhuri
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-10       Impact factor: 10.154
  6 in total
  1 in total

1.  Testing the SF-36 in Parkinson's disease. Implications for reporting rating scale data.

Authors:  P Hagell; A L Törnqvist; J Hobart
Journal:  J Neurol       Date:  2008-01-22       Impact factor: 4.849
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.